Skip to main content
SpringerLink
Log in

Busulfan

  • Chapter
Single Agents in Cancer Chemotherapy

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Galton, D. Chemotherapy of chronic myelocytic leukemia. Seminars Hemat 6: 333, 1969.

    Google Scholar 

  2. Haddow, A., and Timmis, G. Myleran in chronic myeloid leukemia. Chemical constitution and biological action. Lancet 1: 207, 1953.

    Article  Google Scholar 

  3. Calabresi, P., and Welch, A. In “The Pharmacological Basis of Therapeutics” (Goodman, L., and Gilman, A., eds.), 3rd edition, Macmillan Co., New York; pp. 1345–1360, 1965.

    Google Scholar 

  4. Minot, G., Buckman, T., and Isaacs, R. Chronic myelogenous leukemia: age incidence, duration and benefit derived from irradiation. JAMA 82: 1489, 1924.

    Article  Google Scholar 

  5. Galton, D. Myleran in chronic myeloid leukemia. Results of treatment. Lancet 264: 208, 1953.

    Article  PubMed  CAS  Google Scholar 

  6. Hansen, P. Clinical experience with Myleran therapy, especially in myeloid leukaemia. In “Ciba Foundation Symposium on Leukemia Research”, pp. 205–215, 1954.

    Chapter  Google Scholar 

  7. Petrakis, N., Bierman, H., Kelly, K., et al. The effect of 1,4-dimethanesulfonyloxybutane (GT-41 or Myleran) upon leukemia. Cancer 7: 383, 1954.

    Article  PubMed  CAS  Google Scholar 

  8. Videbaek, A. Myleran (GT 41) in the treatment of leukemia. Acta Med Scand 151: 295, 1955.

    Article  PubMed  CAS  Google Scholar 

  9. Louis, J., Limarzi, L., and Best, W. Treatment of chronic granulocytic leukemia with Myleran. Arch Intern Med 97: 299, 1956.

    Article  CAS  Google Scholar 

  10. Hyman, G., and Gellhorn, A. Myleran therapy in malignant neoplastic disease. JAMA 161: 844, 1956.

    Article  CAS  Google Scholar 

  11. Spurr, C., Wilson, W., and McDonald, J. Myleran in the treatment of chronic myeloid leukemia: results of treatment. Southern Med J 49: 847, 1956.

    Article  PubMed  CAS  Google Scholar 

  12. Schilling, R., and Meyer, O. Treatment of chronic granulocytic leukemia with 1,4-dimethanesulfonyloxybutane (Myleran). New Eng J Med 254: 986, 1956.

    Article  PubMed  CAS  Google Scholar 

  13. Greig, H. Myleran in the treatment of chronic myeloid leukaemia. Acta Haemat 16: 171, 1956.

    Article  PubMed  CAS  Google Scholar 

  14. Frost, J., and Jackson, C.- Myleran in the treatment of chronic granulocytic leukemia. JAMA 161: 54, 1956.

    Article  CAS  Google Scholar 

  15. Early, I., and Prichard, R. The treatment of chronic granulocytic leukemia with Myleran. N Carolina Med J 17: 315, 1956.

    PubMed  CAS  Google Scholar 

  16. Unugur, A., Schulman, E., and Dameshek, W. Treatment of chronic granulocytic leukemia with Myleran. New Eng J Med 256: 727, 1957.

    Article  PubMed  CAS  Google Scholar 

  17. Turesson, D. Myleran treatment in chronic granulocytic leukemia. Brit J Haemat 3: 220, 1957.

    Article  PubMed  CAS  Google Scholar 

  18. Bethell, F. Myleran and triethylene melamine in the treatment of chronic granulocytic leukemia. Ann N Y Acad Sci 68: 996, 1958.

    Article  PubMed  CAS  Google Scholar 

  19. Galton, D., Till, M., and Wiltshaw, E. Busulfan (1,4dimethanesulfonyloxybutane, Myleran): summary of clinical results. Ann N Y Acad Sci 68: 967, 1958.

    Article  PubMed  CAS  Google Scholar 

  20. Dameshek, W., Granville, N., and Rubio, F. Therapy of the myeloproliferative disorders with Myleran. Ann N Y Acad Sci 68: 1001, 1958.

    Article  PubMed  CAS  Google Scholar 

  21. Sykes, M. Myleran in the treatment of lymphomas. Ann N Y Acad Sci 68: 1035, 1958.

    Article  PubMed  CAS  Google Scholar 

  22. Sullivan, R. Myleran therapy in bronchogenic carcinoma. Ann N Y Acad Sci 68: 1038, 1958.

    Article  PubMed  CAS  Google Scholar 

  23. Wald, N., Hoshino, T., and Sears, M. Therapy of polycythemia vera with Myleran. Blood 13: 757, 1958.

    PubMed  CAS  Google Scholar 

  24. Louis, J. Treatment of polycythemia vera with busulfan (Myleran). JAMA 168: 1882, 1958.

    Article  Google Scholar 

  25. Wilkinson, J., and Turner, R. Chemotherapy of chronic myeloid leukemia, with special reference to Myleran. In “Progress in Hematology”, (Tocantins, L., ed.), Grune and Stratton, New York and London, Volume 2, pp. 227–238, 1959.

    Google Scholar 

  26. Desai, R. Treatment of chronic granulocytic and lymphocytic leukemia and allied disorders with Myleran and Leukeran in Indian subjects. Acta Haemat Jap 22: 160, 1959.

    Google Scholar 

  27. Rundles, R., Grizzle, J., Bell, W., et al. Comparison of chlorambucil and Myleran in chronic lymphocytic and granulocytic leukemia. Amer J Med 27: 424, 1959.

    Article  Google Scholar 

  28. Ghose, S., and Chatterjea, J. Chronic myeloid leukemia: a study of 116 cases. J Indian Med Assoc 34: 381, 1960.

    PubMed  CAS  Google Scholar 

  29. Xefteris, E., Mitus, W., Mednicoff, I., et al. Leukocytic alkaline phosphatase in busulfan induced remissions of chronic granulocytic leukemia. Blood 18: 202, 1961.

    PubMed  CAS  Google Scholar 

  30. Haut, A., Abbott, W., Wintrobe, M., et al. Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy. Blood 17: 1, 1961.

    PubMed  CAS  Google Scholar 

  31. Bridges, J., Hayes, D., and Nelson, M. Busulfan in the treatment of chronic granulocytic leukemia. Brit J Cancer 15: 468, 1961.

    Article  PubMed  CAS  Google Scholar 

  32. Killmann, S., and Cronkite, E. Treatment of polycythemia vera with Myleran. Amer J Med Sci 241: 218, 1961.

    Article  PubMed  CAS  Google Scholar 

  33. Shullenberger, C. Evaluation of the comparative effectiveness of Myleran and 6 MP in the management of patients with chronic myelocytic leukemia. Cancer Chemother Rep 16: 203, 1962

    PubMed  CAS  Google Scholar 

  34. Huguley, C., Grizzle, J., Rundles, R., et al. Comparison of 6-mercaptopurine and busulfan in chronic granulocytic leukemia. Blood 21: 89, 1963.

    Google Scholar 

  35. Carbone, P., Tjio, J., Whang, J., et al. The effect of treatment in patients with chronic myelogenous leukemia. Hematologic and cytogenetic studies. Ann Intern Med 59: 622, 1963.

    PubMed  CAS  Google Scholar 

  36. Bean, R. Myleran in the treatment of chronic lymphatic leukemia. Israel J Med Sci 1: 801, 1965.

    PubMed  CAS  Google Scholar 

  37. Epstein, I. The treatment of polycythemia vera and thrombocythemia with Myleran (busulphan). Israel J Med Sci 1: 797, 1965.

    PubMed  CAS  Google Scholar 

  38. Arduino, L., and Mellinger, G. Clinical trial of busulfan (NSC 750) in advanced carcinoma of prostate. Cancer Chemother Rep 51: 295, 1967.

    PubMed  CAS  Google Scholar 

  39. Witts, L. (Medical Research Council Working Party). Chronic granulocytic leukemia: comparison of radiotherapy and busulfan therapy. Brit Med J 1: 201, 1968.

    Article  Google Scholar 

  40. Penttila, O., and Ikkala, E. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera. Ann Med Int Fenn 57: 99, 1968.

    PubMed  CAS  Google Scholar 

  41. Gilbert, H. Problems relating to control of polycythemia vera: the use of alkylating agents. Blood 32: 500, 1968.

    Google Scholar 

  42. Brodsky, I., Kahn, S., and Brady, L. Polycythaemia vera: differential diagnosis by ferrokinetic studies and treatment with busulphan (Myleran). Brit J Haemat 14: 351, 1968.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute, Bethesda, Maryland, USA

    Robert B. Livingston & Stephen K. Carter

Authors
  1. Robert B. Livingston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen K. Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1970 IFI/Plenum · New York-Washington-London

About this chapter

Cite this chapter

Livingston, R.B., Carter, S.K. (1970). Busulfan. In: Single Agents in Cancer Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1378-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1378-6_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1380-9

  • Online ISBN: 978-1-4684-1378-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation